Published by Josh White on 29th August 2023
(Sharecast News) - Pharmaceuticals developer Hutchmed China announced on Tuesday that the Center for Drug Evaluation of China's National Medical Products Administration (NMPA) has granted breakthrough therapy designation (BTD) to its investigational drug savolitinib.
URL: http://www.digitallook.com/dl/news/story/33732798/...